...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Notice of Meeting and Management Information Circular

Bear actually summed it all up for us last week in this post...not sure where the confusion came from.

I hope I didn't contribute to it...that was never my intent.

Share
New Message
Please login to post a reply